Merck KGaA (MKKGY) Stock Price & Analysis
Merck KGaA (MKKGY) — price $32.49 (-1.10%), as of the Nov 19, 2026 trading session; market cap $70.6B.
Educational signal · not a buy or sell recommendation · How to read this
Merck KGaA · MKKGY · Healthcare · Drug Manufacturers - Specialty & Generic
Merck KGaA is a leading German science and technology enterprise. Its business operations are strategically organized into three core divisions: Life Science, Healthcare, and Electronics.
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $32.49 | |
| Change on the day | -1.10% | |
| 52-week range | $23.73–$34.19 | |
| Market capitalisation | $70.6B | — |
| Price / earnings (trailing) | 27.66 | |
| Shares traded on the day | 1.8K | |
| Beta (volatility vs the S&P 500) | 0.81 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Merck KGaA (MKKGY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 11, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Merck KGaA (MKKGY), and what does it report?
Short answer · as of
Life Science sells tools, chemicals, equipment, testing products, and process expertise to researchers, biotechnology companies, drug manufacturers, and industrial customers.
Research dated 2026-09-12.
Healthcare develops and commercializes medicines across oncology, neurology, immunology, fertility, endocrinology, and other therapeutic areas, while Electronics supplies semiconductor and display materials alongside delivery systems and surface products.
What do the latest results show for Merck KGaA (MKKGY)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of €5.52B. Against analyst estimates the company has EPS beat 6 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | €5.52B | €498M | €0.23 (diluted) |
| Q1 FY2026 | €5.13B | €659M | €0.30 (diluted) |
| Q4 FY2025 | €5.20B | €316M | €0.14 (diluted) |
| Q3 FY2025 | €5.32B | €902M | €0.41 (diluted) |
What are the financial strengths and risks for Merck KGaA (MKKGY)?
Short answer · as of
The distress and quality screens read Altman Z 3.19 · Piotroski F 7. Trailing ratios: ROE 8.1% · ROA 4.5% · current ratio 1.69 · earnings yield 3.6% · free-cash-flow yield 4.1%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MKKGY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MKKGY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Merck KGaA (MKKGY)?
What Investors Ask About Merck KGaA (MKKGY) — Healthcare
Research dated 2026-09-12; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.
Why is Merck KGaA more than a pharmaceutical manufacturer?
Prescription medicines sit alongside Life Science tools and bioprocessing expertise, plus Electronics materials used in semiconductor, display, and surface applications. Consolidated results therefore reflect laboratory activity and electronics production as well as medicine demand.
How can semiconductor customer bottlenecks affect Merck KGaA?
Merck KGaA supplies materials and delivery systems used by semiconductor customers, so constrained customer capacity can postpone material consumption and limit near-term sales conversion. Management expects those constraints to persist while the industry removes bottlenecks.
What is the MKKGY stock price today?
The last price recorded for Merck KGaA (MKKGY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 17 figures on this page — 13 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com